WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 9 fonti

Democrats Press Trump Admin on Special Access to Obesity Drug

If not the president, then who, senator asks

Raccontata da

newrepublic.com

medpagetoday.com

independent.co.uk

washingtonexaminer.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo10 h fa

Democrats Press Trump Admin on Special Access to Obesity Drug

If not the president, then who, senator asks

Timeline cronologica

martedì 23 giugno 2026·newrepublic.com
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
martedì 23 giugno 2026·newrepublic.com
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

8 h fa

Democrats press White House on who got special access to Eli Lilly’s new obesity drug

The unusual access to an experimental drug has captured the attention of the American public as well.

Leggi questa versione → originale

newrepublic.com2 g fa

Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

Leggi questa versione → originale

forbes.com23 h fa

Dems Demand Answers About Whether Trump Received Experimental Weight Loss Drug

The White House denied earlier this week that the president received priority access to an experimental weight loss drug.

Leggi questa versione → originale

gizmodo.com2 g fa

Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?

The White House has denied that the application was filed on behalf of President Donald Trump.

Leggi questa versione → originale

benzinga.com1 g fa

White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi

White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.

Leggi questa versione → originale

martedì 23 giugno 2026·

statnews.com

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…

martedì 23 giugno 2026·

medpagetoday.com

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

martedì 23 giugno 2026·

gizmodo.com

Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?

The White House has denied that the application was filed on behalf of President Donald Trump.

martedì 23 giugno 2026·

independent.co.uk

White House denies Trump is the mystery patient who got early access to obesity drug

A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’

martedì 23 giugno 2026·

nymag.com

Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?

The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.

mercoledì 24 giugno 2026·

independent.co.uk

White House denies Trump was mystery patient given early access to weight-loss drug

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…

mercoledì 24 giugno 2026·

washingtonexaminer.com

White House denies report Trump got access to experimental weight loss drug

The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.

mercoledì 24 giugno 2026·

benzinga.com

White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi

White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.

giovedì 25 giugno 2026·

forbes.com

Dems Demand Answers About Whether Trump Received Experimental Weight Loss Drug

The White House denied earlier this week that the president received priority access to an experimental weight loss drug.

giovedì 25 giugno 2026·

medpagetoday.com

Democrats Press Trump Admin on Special Access to Obesity Drug

If not the president, then who, senator asks

giovedì 25 giugno 2026·

statnews.com

Democrats press White House on who got special access to Eli Lilly’s new obesity drug

The unusual access to an experimental drug has captured the attention of the American public as well.